Literature DB >> 1240

Problems with practolol.

H J Wall-Manning.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1240     DOI: 10.2165/00003495-197510050-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  19 in total

1.  Untoward effects associated with practolol: demonstration of antibody binding to epithelial tissue.

Authors:  H E Amos; W D Brigden; R A McKerron
Journal:  Br Med J       Date:  1975-03-15

2.  Oculocutaneous reaction to oxprenolol.

Authors:  P J Holt; E Waddington
Journal:  Br Med J       Date:  1975-06-07

3.  Untoward effects associated with practolol administration: oculomucocutaneous syndrome.

Authors:  P Wright
Journal:  Br Med J       Date:  1975-03-15

4.  Letter: practolol-induced pleurisy and constrictive pericarditis.

Authors:  N H Dyer; C C Varley
Journal:  Br Med J       Date:  1975-05-24

5.  Letter: beta-blockers and fibrinous peritonitis.

Authors:  J F Gurry; I G Cunningham; B N Brooke
Journal:  Br Med J       Date:  1975-05-31

6.  Fibrinous peritonitis: a complication of practolol therapy.

Authors:  W O Windsor; F Durrein; N H Dyer
Journal:  Br Med J       Date:  1975-04-12

7.  Letter: Skin reactions to beta-blockers.

Authors:  J B Cumberbatch
Journal:  Br Med J       Date:  1974-11-30

8.  Letter: Skin reactions to practolol.

Authors:  R Felix; F A Ive
Journal:  Br Med J       Date:  1974-05-11

9.  Letter: Practolol and sclerosing peritonitis.

Authors:  R H Meyboom
Journal:  Lancet       Date:  1975-02-08       Impact factor: 79.321

10.  Systemic lupus erythematosus syndrome induced by practolol.

Authors:  E B Raftery; A M Denman
Journal:  Br Med J       Date:  1973-05-26
View more
  6 in total

Review 1.  Hypertension: which beta-blocker?

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1976-12       Impact factor: 9.546

2.  Irreversible protein binding of [14C]-practolol metabolite(s) to hamster liver microsomes (proceedings).

Authors:  T C Orton; C Lowery; W E Lindup
Journal:  Br J Pharmacol       Date:  1977-06       Impact factor: 8.739

3.  Adverse reactions to practolol in hospitalized patients: a report from the Boston Collaborative Drug Surveillance Program.

Authors:  H J Pfeifer; D J Greenblatt; J Koch-Weser
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

4.  Comparison of methods to detect side-effect on clinical application of chloranolol, a beta-adrenergic receptor inhibitor.

Authors:  E Török; E Kósa; M Szontagh; P Juvancz; J Eggenhofer; J Borvendég
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Endralazine, a new peripheral vasodilator. Evaluation of safety and efficacy over a 3 year period.

Authors:  W A Bogers; L Meems
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 6.  Antinuclear antibodies and cardiovascular drugs.

Authors:  J D Wilson
Journal:  Drugs       Date:  1980-04       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.